Sage Journals: Discover world-class research

Retricted access

Review article

First published 2023-11

X-linked hypophosphatemia,fibroblast growth factor 23 signaling,and craniosynostosis

Chelsey Grimbly, Daniel Graf, Leanne M Ward [...]

Experimental Biology and Medicine

Open access

Research article

First published 2026-2

Two-year structural skeletal outcomes of burosumab therapy in pediatric X-linked hypophosphatemia: A radiographic cohort study

Hayeon Lim, Wonik Lee, Naye Choi [...]

Journal of Children's Orthopaedics

Retricted access

Research article

First published 2017-4

Phosphate and Vitamin D Prevent Periodontitis in X-Linked Hypophosphatemia

M. Biosse Duplan, B.R. Coyac, C. Bardet [...]

Journal of Dental Research

Open access

Research article

First published 2021

Body composition and cardiometabolic health of pediatric patients with X-linked hypophosphatemia (XLH) under burosumab therapy

Avivit Brener, Yael Lebenthal, Roxana Cleper [...]

Therapeutic Advances in Endocrinology and Metabolism

Open access

Research article

First published 2024

Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis

Annemieke M. Boot, Gema Ariceta, Signe Sparre Beck-Nielsen [...]

Sage Open Chronic Disease

Retricted access

Research article

First published 2018-2

Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures

B.R. Coyac, B. Hoac, P. Chafey [...]

Journal of Dental Research

Retricted access

Research article

First published 2023-06

Efficacy of Burosumab Every 2 Weeks in an Adult with X-Linked Hypophosphatemia: Should We Learn from Children?

Alessia Marcellino, Silvia Bloise, Carmelo Pirone [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Retricted access

Research article

First published 2020-4

Dentoalveolar Defects in the Hyp Mouse Model of X-linked Hypophosphatemia

H. Zhang, M.B. Chavez, T.N. Kolli [...]

Journal of Dental Research

Open access

Review article

First published 2022

What are the benefits of the anti-FGF23 antibody burosumab on the manifestations of X-linked hypophosphatemia in adults in comparison with conventional therapy? A review

Marie-Hélène Lafage-Proust

Therapeutic Advances in Rare Disease

Free access

Research article

First published 2018-12

Vibrational spectroscopic analysis of hydroxyapatite in HYP mice and individuals with X-linked hypophosphatemia

Eva Amenta, Helen E. King, Holger Petermann [...]

Sage Open Chronic Disease

Search results